Comparison of Subconjuctival and Intracameral dexamethasone in controlling uveitis post SICS
Abstract
To study the effectiveness of Subconjuctival
injection of Dexamethasone versus Intracameral injection of
Dexamethasone in controlling uveitis post SICS, a
prospective study was conducted for a period of twelve
months from January to December 2015.In this study 100
patients were studied. Patients who are diagnosed to have
senile uncomplicated cataract were divided into two groups.
Group A-50 patients received subconjuctival
dexamethasone0.5ml(2mg). Group B-50 patients received
intracameral dexamethasone0.1ml(0.4mg).There was 4-6
percent decrease in the incidence of anterior uveitis after
cataract surgery immediately in 1st and 3rd post-operative
days in Group B compared to Group AFull Text:
PDFReferences
Rowen S.Preoperative and post operative medications used for cataract surgery.Curr Opin Ophthalmol 1990;10:29-35.
Ahmed MS,Moly KN.Use of povidine iodine drop instead of subconjuctival injection of dexamethasone at the end of cataract surgery.
Ichigashira N,Yamaga N.Intraocular fate of dexamethasone phosphate topically applied to eyes.Steriods 1978;32(5):615-628.
Wadood AC,Armbrecht AM,Aspinall.Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after cataract surgery.
Molean EB.Inadvertent injection of corticosteroid into choroidal vasculature. Am J Ophthalmol.1975;80(5): 835-837
Corbett MC, Hingorani M.Subconjuctival betamethasone is of benefit after cataract surgery Eye 1993.7 (Pt 6) 744-748.
Bakri JB.Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003;34(5):386-390
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University